Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Esophageal adenocarcinoma (EAC) incidence is increasing rapidly. Esophageal cancer has the second lowest 5-year survival rate of people diagnosed with cancer in Canada. Given the poor survival and the potential for further increases in incidence, phase-specific cost estimates constitute an important input for economic evaluation of prevention, screening, and treatment interventions. | Estimates and predictors of health care costs of esophageal adenocarcinoma A population-based cohort study
